Portfoliotracker

Shanghai Medicilon Inc.

688202.SS · SHANGHAI · Healthcare Biotechnology 24/100 E

74,52 CNY
▲ +0,30 (+0,40 %)
Closed delayed by 15 min
Price as of 17. 11. 08:00, fetched 17. 11. 14:35
Next earnings–
Ex-dividend–
Analysts–
50 / 200 day average– / –

Price

Portfoliotracker score24 / 100 Market cap9,83 mld. CNY P/E– Forward P/E34,2 P/S7,1 P/B4,9 EV/EBITDA1 475,3 Dividend yield– FCF yield0,18 % EPS-0,34 CNY Net margin-3,0 % Return on equity-2,2 % Beta0,90 Debt / equity0,10
52-week range 50,50 to 120,00
3-month average volume7,1 M

Finance

Where the revenue goes

Loading the income statement flow…

Fundamentals

Loading key figures…

Insiders, analysts and people

All trades and changes

Loading insiders, analysts and opinions…

Co se právě děje

AI souhrn
Objednat AI souhrn, co se u firmy právě děje Vytvoří se jednou na pozadí a pak ho uvidí všichni. Ve verzi Free 3 objednávky měsíčně.

About the company

Shanghai Medicilon Inc., a contract research organization, provides drug discovery and development services to pharmaceutical and biotechnology companies in China and internationally. The company operates in Drug Discovery and Pharmaceutical Research, and Preclinical Research segments. It offers drug discovery, CMC development, preclinical research, biology, chemistry, catalyst screening, flow chemistry, carbohydrate chemistry, analytical chemical, ADME/DMPK, pharmacology, safety assessment, IND-Enabling studies, and advanced technology services. The company also provides peptide, SiRNA, ADC, Protac, AOCs, NAMs Platforms. The company was founded in 2004 and is based in Shanghai, China.

Employees
2 504
Country
China
Data since
5. 11. 2019

Explore further

Similar companies 688180.SS603127.SS

Intraday chart

Your own portfolio, properties and finances in one place.

The account is free with no time limit. Only you see your data; nobody adds it up with others.

This is saved to your account. You can keep browsing, calculating and comparing without signing in.

Welcome back

Sign in and pick up where you left off.

or continue with

No account yet? Create a free account